CCR5 is a receptor for Staphylococcus aureus leukotoxin ED

Nature

Volumn 493, Issue 7430, 2013, Pages 51-55

  Alonzo III, Francis ^a   Kozhaya, Lina ^a   Rawlings, Stephen A ^a   Reyes Robles, Tamara ^a   Dumont, Ashley L ^a   Myszka, David G ^b   Landau, Nathaniel R ^a   Unutmaz, Derya ^a   Torres, Victor J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Biosensor Tools LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; LEUKOTOXIN; MARAVIROC;

BACTERIUM; DRUG; HOST-PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE SYSTEM; RODENT; TOXIN; VIRULENCE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL KILLING; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNE EVASION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE;

ANIMALS; BACTERIAL TOXINS; CELL DEATH; CELLS, CULTURED; DENDRITIC CELLS; EXOTOXINS; FEMALE; HUMANS; IMMUNE EVASION; IMMUNOLOGIC MEMORY; JURKAT CELLS; MICE; MYELOID CELLS; RECEPTORS, CCR5; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; MUS; STAPHYLOCOCCUS AUREUS;

EID: 84871814560     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11724     Document Type: Article

References (44)

1. Foster, T. J. Immune evasion by staphylococci. Nature Rev. Microbiol. 3, 948-958 (2005). (Pubitemid 43078158)
2. Bischofberger, M., Iacovache, I. & Gisou van der Goot, F. Pathogenic pore-forming proteins: function and host response. Cell Host Microbe 12, 266-275 (2012).
3. Menestrina, G. et al. Ion channels and bacterial infection: the case of b-barrel poreforming protein toxins of Staphylococcus aureus. FEBS Lett. 552, 54-60 (2003). (Pubitemid 37103009)
4. Dumont, A. L. et al. Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol. Microbiol. 79, 814-825 (2011).
5. Van de Velde, H. Etude sur le mécanisme de la virulence du staphylocoque pyogène. Cellule 10, 403-460 (1894).
6. Panton, P. N. & Valentine, F. C. O. Staphylococcal toxin. Lancet i, 506-508 (1932).
7. Alonzo, F. III et al. Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol. Microbiol. 83, 423-435 (2012).
8. Morner, A. et al. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently useCCR5but showpromiscuity in coreceptor usage. J. Virol. 73, 2343-2349 (1999). (Pubitemid 29098139)
9. Deng, H. et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666 (1996). (Pubitemid 26197679)
10. Doranz, B. J. et al. A dual-tropic primary HIV-1 isolate that uses fusin and the betachemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158 (1996). (Pubitemid 26235280)
11. Didigu, C. A. & Doms, R. W. Novel approaches to inhibit HIV entry. Viruses 4, 309-324 (2012).
12. Strizki, J. M. et al. Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 49, 4911-4919 (2005). (Pubitemid 41782160)
13. Baba, M. et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl Acad. Sci. USA 96, 5698-5703 (1999). (Pubitemid 29234681)
14. Lee, B. et al. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J. Biol. Chem. 274, 9617-9626 (1999).
15. Rich, R. L., Miles, A. R., Gale, B. K. & Myszka, D. G. Detergent screening of a G-protein-coupled receptor using serial and array biosensor technologies. Anal. Biochem. 386, 98-104 (2009).
16. Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377 (1996). (Pubitemid 26272077)
17. Samson, M. et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutantallelesof theCCR-5chemokinereceptorgene. Nature382,722-725(1996).
18. El Hed, A. et al. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J. Infect. Dis. 201, 843-854 (2010).
19. Wan, Q. et al. Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR61 human memory T cells. J. Exp. Med. 208, 1875-1887 (2011).
20. Saita, Y., Kondo, M. & Shimizu, Y. Species selectivity of small-molecular antagonists for the CCR5 chemokine receptor. Int. Immunopharmacol. 7, 1528-1534 (2007). (Pubitemid 47499257)
21. Golding, H. et al. Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii. Blood 102, 3280-3286 (2003). (Pubitemid 37314767)
22. Aliberti, J. et al. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat. Immunol. 4, 485-490 (2003). (Pubitemid 36592442)
23. Rahbar, R., Murooka, T. T. & Fish, E. N. Role for CCR5 in dissemination of vaccinia virus in vivo. J. Virol. 83, 2226-2236 (2009).
24. Lalani, A. S. et al. Use of chemokine receptors by poxviruses. Science 286, 1968-1971 (1999). (Pubitemid 129515908)
25. Hummel, S., Schmidt, D., Kremeyer, B., Herrmann, B. & Oppermann, M. Detection of the CCR5-D32 HIV resistance gene in Bronze Age skeletons. Genes Immun. 6, 371-374 (2005). (Pubitemid 40903412)
26. Lucotte, G. Frequencies of32 base pair deletion of the (D32) allele of theCCR5HIV-1 co-receptor gene in Caucasians: a comparative analysis. Infect. Genet. Evol. 1, 201-205 (2002). (Pubitemid 34461233)
27. Hedrick, P. W. & Verrelli, B. C. 'Ground truth' for selection on CCR5-D32. Trends Genet. 22, 293-296 (2006).
28. Moore, P. C. & Lindsay, J. A. Molecular characterisation of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA-16. J. Med. Microbiol. 51, 516-521 (2002). (Pubitemid 34492981)
29. Vandenesch, F. et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwideemergence.Emerg. Infect. Dis. 9, 978-984 (2003). (Pubitemid 36944519)
30. von Eiff, C., Friedrich, A. W., Peters, G.&Becker, K. Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 49, 157-162 (2004). (Pubitemid 38891721)
31. DeLeo, F. R. et al. Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci USA 108, 18091-18096 (2011).
32. Zielinski, C. E. et al. Pathogen-induced human TH17 cells produce IFN-c or IL-10 and are regulated by IL-1b. Nature 484, 514-518 (2012).
33. Cho, J. S. et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J. Clin. Invest. 120, 1762-1773 (2010).
34. Lin, L. et al. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 5, e1000703 (2009).
35. Oswald-Richter, K. et al. Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection. PLoS Pathog. 3, e58 (2007).
36. Gramberg, T., Sunseri, N.&Landau, N. R. Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx. J. Virol. 84, 1387-1396 (2010).
37. Manel, N. et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467, 214-217 (2010).
38. Berro, R. et al. Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors. J. Virol. 85, 8227-8240 (2011).
39. Stenlund, P., Babcock, G. J., Sodroski, J. & Myszka, D. G. Capture and reconstitution of G protein-coupled receptors on a biosensor surface. Anal. Biochem. 316, 243-250 (2003). (Pubitemid 36444554)
40. Navratilova, I., Sodroski, J. & Myszka, D. G. Solubilization, stabilization, and purification of chemokine receptors using biosensor technology. Anal. Biochem. 339, 271-281 (2005). (Pubitemid 40395285)
41. Navratilova, I., Dioszegi, M. & Myszka, D. G. Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology. Anal. Biochem. 355, 132-139 (2006). (Pubitemid 44041399)
42. Navratilova, I., Pancera, M., Wyatt, R. T. & Myszka, D. G. A biosensor-based approach toward purification and crystallization of G protein-coupled receptors. Anal. Biochem. 353, 278-283 (2006). (Pubitemid 43775440)
43. Caccuri, F. et al. HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2. Proc. Natl Acad. Sci. USA 109, 14580-14585 (2012).
44. Giagulli, C. et al. HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity onmonocytes through Rho/ROCK activation. Blood 119, 2274-2283 (2012).